(Q39715997)

14 September 2017

Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake (English)

1 reference

14 September 2017

1 reference

Valentina K Todorova

1

1 reference

14 September 2017

Yihong Kaufmann

series ordinal

2

1 reference

14 September 2017

Shaoke Luo

series ordinal

3

1 reference

14 September 2017

V Suzanne Klimberg

series ordinal

4

1 reference

14 September 2017

language of work or name

1 reference

11 April 2010

1 reference

Cancer Chemotherapy and Pharmacology

14 September 2017

1 reference

14 September 2017

67

1 reference

14 September 2017

285-291

1 reference

14 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-010-1316-y

14 September 2017

0 references

cites work

Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma. The Yorkshire Gastrointestinal Tumour Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Mechanisms of tamoxifen-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Glutamine metabolism in Ehrlich ascites-carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Glutamine availability up-regulates expression of the amino acid transporter protein ASCT2 in HepG2 cells and stimulates the ASCT2 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Tamoxifen but not 4-hydroxytamoxifen initiates apoptosis in p53(-) normal human mammary epithelial cells by inducing mitochondrial depolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Tamoxifen induces oxidative stress and mitochondrial apoptosis via stimulating mitochondrial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Cellular reducing equivalents and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Biologic and pharmacologic regulation of mammalian glutathione synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Glutamine, as a precursor of glutathione, and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Molecular mechanisms of N-acetylcysteine actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Deviant energetic metabolism of glycolytic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Relevance of glutamine metabolism to tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1316-Y

10.1007/S00280-010-1316-Y

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference